Drug profile · INN
dextroamphetamine
XELSTRYM
dextroamphetamine (XELSTRYM) is a norepinephrine transporter releasing agent. Route of administration: transdermal. Current US regulatory status: approved.
Drug details — dextroamphetamine
- US status
- approved
- Class
- —
- Route
- TRANSDERMAL
- Patents
- 0
- Programs
- 3
- Data quality
- 0.84
Quick answer
dextroamphetamine (XELSTRYM) is a norepinephrine transporter releasing agent. Route of administration: transdermal. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter releasing agent
Primary target: Sodium-dependent dopamine transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is dextroamphetamine?
dextroamphetamine (XELSTRYM) is a norepinephrine transporter releasing agent. Route of administration: transdermal. Current US regulatory status: approved.
What is the brand name for dextroamphetamine?
XELSTRYM is a marketed brand name for dextroamphetamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dextroamphetamine?
dextroamphetamine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.